Royal Bank Of Canada Chembio Diagnostics, Inc. Transaction History

Royal Bank Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.25 - $0.45 $56 - $101	226 Added 513.64%	270 $0
Q4 2022 Feb 14, 2023	SELL	$0.2 - $0.33 $11 - $18	-56 Reduced 56.0%	44 $0
Q3 2022 Nov 14, 2022	BUY	$0.35 - $1.1 $35 - $110	100 New	100 $0
Q4 2021 Feb 14, 2022	SELL	$1.09 - $2.55 $3,290 - $7,698	-3,019 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.06 - $5.34 $2,908 - $7,540	-1,412 Reduced 31.87%	3,019 $8,000
Q2 2021 Aug 16, 2021	BUY	$2.88 - $5.64 $12,761 - $24,990	4,431 New	4,431 $13,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.